Practical Management Guide for Clinicians Who Treat Patients with Amiodarone

Andrew E. Epstein, Brian Olshansky, Gerald Naccarelli, John I. Kennedy, Elizabeth J. Murphy, Nora Goldschlager

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

Amiodarone, an iodinated benzofuran derivative with Class I, II, III, and IV antiarrhythmic properties, is the most commonly used antiarrhythmic drug used to treat supraventricular and ventricular arrhythmias. Appropriate use of this drug, with its severe and potentially life-threatening adverse effects, requires an essential understanding of its risk-benefit properties in order to ensure safety. The objective of this review is to afford clinicians who treat patients receiving amiodarone an appropriate management strategy for its safe use. The authors of this consensus management guide have thoroughly reviewed and evaluated the existing literature on amiodarone and apply this information, along with the collective experience of the authors, in its development. Provided are management guides on the intravenous and oral dosing of amiodarone, appropriate outpatient follow-up of patients taking the drug, its recognized adverse effects, and recommendations on when to consult specialists to help in patient management. All clinicians must be cognizant of the appropriate use, follow-up, and adverse reactions of amiodarone. The responsibility incurred by those treating such patients cannot be overemphasized.

Original languageEnglish (US)
Pages (from-to)468-475
Number of pages8
JournalAmerican Journal of Medicine
Volume129
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Amiodarone
Anti-Arrhythmia Agents
Pharmaceutical Preparations
Cardiac Arrhythmias
Outpatients
Safety

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Epstein, A. E., Olshansky, B., Naccarelli, G., Kennedy, J. I., Murphy, E. J., & Goldschlager, N. (2016). Practical Management Guide for Clinicians Who Treat Patients with Amiodarone. American Journal of Medicine, 129(5), 468-475. https://doi.org/10.1016/j.amjmed.2015.08.039
Epstein, Andrew E. ; Olshansky, Brian ; Naccarelli, Gerald ; Kennedy, John I. ; Murphy, Elizabeth J. ; Goldschlager, Nora. / Practical Management Guide for Clinicians Who Treat Patients with Amiodarone. In: American Journal of Medicine. 2016 ; Vol. 129, No. 5. pp. 468-475.
@article{0dfa3055bea84ae19416e1a7a6486a25,
title = "Practical Management Guide for Clinicians Who Treat Patients with Amiodarone",
abstract = "Amiodarone, an iodinated benzofuran derivative with Class I, II, III, and IV antiarrhythmic properties, is the most commonly used antiarrhythmic drug used to treat supraventricular and ventricular arrhythmias. Appropriate use of this drug, with its severe and potentially life-threatening adverse effects, requires an essential understanding of its risk-benefit properties in order to ensure safety. The objective of this review is to afford clinicians who treat patients receiving amiodarone an appropriate management strategy for its safe use. The authors of this consensus management guide have thoroughly reviewed and evaluated the existing literature on amiodarone and apply this information, along with the collective experience of the authors, in its development. Provided are management guides on the intravenous and oral dosing of amiodarone, appropriate outpatient follow-up of patients taking the drug, its recognized adverse effects, and recommendations on when to consult specialists to help in patient management. All clinicians must be cognizant of the appropriate use, follow-up, and adverse reactions of amiodarone. The responsibility incurred by those treating such patients cannot be overemphasized.",
author = "Epstein, {Andrew E.} and Brian Olshansky and Gerald Naccarelli and Kennedy, {John I.} and Murphy, {Elizabeth J.} and Nora Goldschlager",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.amjmed.2015.08.039",
language = "English (US)",
volume = "129",
pages = "468--475",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5",

}

Epstein, AE, Olshansky, B, Naccarelli, G, Kennedy, JI, Murphy, EJ & Goldschlager, N 2016, 'Practical Management Guide for Clinicians Who Treat Patients with Amiodarone', American Journal of Medicine, vol. 129, no. 5, pp. 468-475. https://doi.org/10.1016/j.amjmed.2015.08.039

Practical Management Guide for Clinicians Who Treat Patients with Amiodarone. / Epstein, Andrew E.; Olshansky, Brian; Naccarelli, Gerald; Kennedy, John I.; Murphy, Elizabeth J.; Goldschlager, Nora.

In: American Journal of Medicine, Vol. 129, No. 5, 01.05.2016, p. 468-475.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Practical Management Guide for Clinicians Who Treat Patients with Amiodarone

AU - Epstein, Andrew E.

AU - Olshansky, Brian

AU - Naccarelli, Gerald

AU - Kennedy, John I.

AU - Murphy, Elizabeth J.

AU - Goldschlager, Nora

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Amiodarone, an iodinated benzofuran derivative with Class I, II, III, and IV antiarrhythmic properties, is the most commonly used antiarrhythmic drug used to treat supraventricular and ventricular arrhythmias. Appropriate use of this drug, with its severe and potentially life-threatening adverse effects, requires an essential understanding of its risk-benefit properties in order to ensure safety. The objective of this review is to afford clinicians who treat patients receiving amiodarone an appropriate management strategy for its safe use. The authors of this consensus management guide have thoroughly reviewed and evaluated the existing literature on amiodarone and apply this information, along with the collective experience of the authors, in its development. Provided are management guides on the intravenous and oral dosing of amiodarone, appropriate outpatient follow-up of patients taking the drug, its recognized adverse effects, and recommendations on when to consult specialists to help in patient management. All clinicians must be cognizant of the appropriate use, follow-up, and adverse reactions of amiodarone. The responsibility incurred by those treating such patients cannot be overemphasized.

AB - Amiodarone, an iodinated benzofuran derivative with Class I, II, III, and IV antiarrhythmic properties, is the most commonly used antiarrhythmic drug used to treat supraventricular and ventricular arrhythmias. Appropriate use of this drug, with its severe and potentially life-threatening adverse effects, requires an essential understanding of its risk-benefit properties in order to ensure safety. The objective of this review is to afford clinicians who treat patients receiving amiodarone an appropriate management strategy for its safe use. The authors of this consensus management guide have thoroughly reviewed and evaluated the existing literature on amiodarone and apply this information, along with the collective experience of the authors, in its development. Provided are management guides on the intravenous and oral dosing of amiodarone, appropriate outpatient follow-up of patients taking the drug, its recognized adverse effects, and recommendations on when to consult specialists to help in patient management. All clinicians must be cognizant of the appropriate use, follow-up, and adverse reactions of amiodarone. The responsibility incurred by those treating such patients cannot be overemphasized.

UR - http://www.scopus.com/inward/record.url?scp=84975742248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975742248&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2015.08.039

DO - 10.1016/j.amjmed.2015.08.039

M3 - Review article

C2 - 26497904

AN - SCOPUS:84975742248

VL - 129

SP - 468

EP - 475

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 5

ER -